Trifluridine in resistant human herpetic keratitis

Arch Ophthalmol. 1978 Oct;96(10):1839-41. doi: 10.1001/archopht.1978.03910060351011.

Abstract

Patients with active dendritic herpetic keratitis that was unresponsive to topical idoxuridine or vidarabine therapy were treated topically with a 1% solution of trifluridine. The dendritic ulcers healed in an average time of 6.1 days. All patients tolerated the drug well except for one patient in whom a reversible crystalline epithelial keratitis developed.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Humans
  • Keratitis, Dendritic / drug therapy*
  • Male
  • Thymidine / analogs & derivatives*
  • Trifluridine / adverse effects
  • Trifluridine / therapeutic use*

Substances

  • Trifluridine
  • Thymidine